top of page
Signal Hill Cape Town South Africa

Shaping African
Precision Oncology For a Better Tomorrow

We're building the next generation of liquid biopsy multi-cancer early-detection tests using uniquely African datasets for enhanced precision and reduced clinical bias.

 

We're building that here, in Africa.

From Africa, to the World.

PRODUCT

WHY LIQUID BIOPSY?

Liquid biopsy screens provide several advantages over traditional tissue biopsies, most notably it's comparatively low invasiveness.

For patients for which tissue-based testing is not appropriate or available, liquid biopsy can provide a safe alternative for diagnosis.

Blood Sample

HOW IT WORKS

01

BLOOD DRAW

A blood sample is all we need to confirm or make a primary diagnosis. No invasive surgeries, no delays.

02

ANALYSIS

We analyse a proprietary list of the most relevant biomarkers through our state of the art machine learning platform.

03

DIAGNOSIS

We provide a report to the primary care physician outlining the primary diagnosis confirmation and cancer type.

ABOUT

Meet the Team

We're on a mission to change the way cancer is diagnosed. Pleased to meet you.

Everyone needs a little advice sometimes...

The first step to knowing everything is knowing that you don't.

Our advisors cover the four pillars of our core business:

Cancer Biology, Bioinformatics, Ethics, and of course Business.

FEATURED
CONTACT

GET IN TOUCH

General inquiries: info@axaitech.co.za
Cell: +27 79 596 6030
Alt: +27 84 697 1122

FOR INVESTORS

Axaitech is currently looking to expand our technology platform. 
If you're an investor looking to build the future of liquid biopsy diagnostics, we'd love to tell you more!

Thank you, we will be in touch shortly.

DEMO
bottom of page